What Is the Average Dose of Vyvanse for Adults?

Most adults prescribed Vyvanse (lisdexamfetamine) end up on a dose somewhere between 30 mg and 70 mg per day, with 70 mg being the FDA-approved ceiling. There is no single “average” dose that applies to everyone, because prescribers are supposed to start low and titrate upward until symptoms improve or side effects become limiting. The starting dose is typically 30 mg each morning, and real-world prescribing data from Europe shows the vast majority of patients stay at or below 70 mg daily. What makes Vyvanse dosing interesting is that the differences in symptom improvement between the lowest and highest approved doses are smaller than most people expect.

The Approved Dose Range

Vyvanse is available in capsules ranging from 10 mg to 70 mg. For adults with ADHD, prescribers generally begin at 30 mg once daily and increase by 10 mg or 20 mg at roughly weekly intervals, based on how well the medication controls symptoms and how tolerable the side effects are. The maximum approved dose is 70 mg per day, and no clinical trials in ADHD have studied doses above that threshold.¹ A large observational study across several European countries found that the average daily dose stayed at or below 70 mg for the overwhelming majority of patients, with between about 80% and nearly 100% of adults falling in that range depending on the country.²

In practice, many adults settle on 50 mg or 70 mg after the titration period, though a meaningful number do well on 30 mg or 40 mg and never need to go higher. The “right” dose is whichever produces adequate symptom control without side effects that outweigh the benefit. That sounds like a non-answer, but it reflects how stimulant dosing actually works: body weight is a poor predictor of optimal dose, and two adults of similar size can land on very different maintenance doses for reasons that are not fully understood.

Does a Higher Dose Actually Work Better?

This is the question most adults have when they are sitting at 30 mg and wondering whether bumping up would make a noticeable difference. The evidence is surprisingly mixed. All approved doses of Vyvanse, from 30 mg through 70 mg, outperform placebo by a clear margin on standard ADHD symptom scales, measures of global improvement, and tests of executive function.³ A meta-analysis that examined the dose-response relationship found that the symptom improvement at 30 mg, 50 mg, and 70 mg did not differ significantly from one another. The effect sizes were roughly 0.70 for 30 mg, 0.81 for 50 mg, and 0.90 for 70 mg, with overlapping confidence intervals across all three.⁴

Those numbers show a trend toward slightly better scores at higher doses, but the differences were not statistically significant. For you, that means if 30 mg or 40 mg is working reasonably well and you are tolerating it, the jump to 70 mg may not produce the dramatic improvement you imagine. On the other hand, some individuals genuinely do not reach adequate symptom control until they hit 60 mg or 70 mg, and the group averages mask that real individual variation. The lack of a strong dose-response signal in clinical trials does not mean dose does not matter for any given person. It means the population-level data cannot tell you which dose is your dose.

Why Vyvanse Doses Feel Smoother Than Some Other Stimulants

Vyvanse is not active in the form you swallow. The capsule contains lisdexamfetamine, a molecule that consists of the amino acid lysine bonded to d-amphetamine. Your body has to break that bond before the active drug becomes available. This conversion happens primarily inside red blood cells, where enzymes clip off the lysine piece and release d-amphetamine gradually.⁵ In lab experiments, the intact prodrug disappeared from whole blood with a half-life of about 1.6 hours, and roughly 82% of it was converted within four hours.⁵ Importantly, the prodrug was completely stable in plasma alone, meaning the conversion requires the cellular machinery inside red blood cells rather than happening freely in the bloodstream.⁶

This built-in rate-limiting step is part of why Vyvanse tends to produce a smoother, longer arc of effect compared to immediate-release amphetamine formulations. It also means that taking a bigger dose does not cause a sharper spike the way doubling a dose of immediate-release medication might. The conversion machinery can only work so fast. That pharmacological “speed limit” is part of the drug’s design and is one reason prescribers feel relatively comfortable titrating within the approved range.

Food, Timing, and How You Take It

A common worry is whether eating breakfast before or after taking Vyvanse changes how well it works. The short answer is that food has no meaningful effect on how much active drug you ultimately absorb. A crossover study in healthy adults found that the total amount of d-amphetamine reaching the bloodstream was essentially the same whether the 70 mg capsule was taken on an empty stomach, with a meal, or dissolved in water as a solution.⁷ The one difference was timing: when taken with food, the peak blood level of d-amphetamine arrived about an hour later than it did on an empty stomach. The overall exposure was the same, just slightly shifted.

For most adults, this means you can take Vyvanse with or without food and not worry about losing effectiveness. If you find that taking it on an empty stomach gives you a jittery onset or nausea, eating beforehand will slow the peak slightly without reducing the total dose your body sees. If you prefer the medication to kick in as quickly as possible, taking it before breakfast will get you there a bit sooner. Neither approach changes your effective dose.

When the Maximum Dose Is Lower Than 70 mg

Not every adult can safely go up to 70 mg. The clearest example is kidney function. Because lisdexamfetamine and its active metabolite are cleared partly through the kidneys, impaired kidney function causes the drug to hang around longer, effectively making each milligram more potent. A pharmacokinetic study established specific caps: adults with severe kidney impairment should not exceed 50 mg per day, and those with end-stage renal disease should stay at 30 mg per day or below.⁸ These are not suggestions. They are hard limits in the prescribing information, and if your kidney function sits in that range, your “average dose” ceiling is lower than the general population’s.

Age is another factor. Adults over 50, and especially those over 65, are more likely to have cardiovascular conditions, reduced kidney or liver function, and other medications on board that interact with stimulants. Expert guidance recommends that older adults start at the lowest available dose and increase more slowly than younger patients, with a thorough physical exam before treatment begins.⁹ The concern is not that Vyvanse is inherently dangerous after a certain birthday, but that the risk of side effects, particularly elevated heart rate and blood pressure, rises when the body’s capacity to handle stimulant medication is diminished by aging or comorbid health conditions.

Side Effects and How They Relate to Dose

The most commonly reported side effects in adults taking Vyvanse include decreased appetite, dry mouth, trouble sleeping, increased heart rate, and feeling jittery or anxious. These tend to be more pronounced at higher doses, which is one of the main reasons prescribers start at 30 mg rather than jumping to 70 mg. Appetite suppression is often the side effect that adults notice most and that persists longest. Some people lose a meaningful amount of weight during the first few months of treatment, and for those already underweight, this can be a genuine clinical concern that limits the dose a prescriber is willing to use.

Cardiovascular effects deserve specific mention. Stimulants as a class modestly raise heart rate and blood pressure in most people who take them. At the 30 mg dose this change is usually small enough to be clinically insignificant, but at 70 mg the bump can be larger and more relevant, especially if you have pre-existing hypertension or a heart rhythm issue. This is another reason the titration approach matters: going up gradually lets your prescriber monitor these numbers at each step rather than discovering a problem after you have been on a high dose for weeks.

One nuance worth knowing: because the dose-response curve for efficacy is relatively flat between 30 mg and 70 mg (as discussed earlier), while side effects tend to climb more steeply with dose, there can be a sweet spot for a given person where symptom improvement is nearly as good at a moderate dose but side effects are meaningfully lower. Prescribers who are thoughtful about titration will try to find that point rather than defaulting to the maximum.

Why Your Optimal Dose Is Hard to Predict

It would be convenient if there were a formula that took your weight, age, and ADHD severity and output the right dose. There is not. Stimulant pharmacology varies substantially between individuals for reasons that are not all well understood. Differences in how fast people metabolize the drug, how sensitive their dopamine receptors are, and how much baseline dopamine activity they have all contribute to the range of responses seen at any given dose.¹⁰ Genetic variation in drug-metabolizing enzymes and in dopamine and norepinephrine transporters likely plays a role, but pharmacogenomic testing for stimulant dosing is not yet standard practice because the predictive value remains modest.

What this means practically is that dosing Vyvanse is still a trial-and-error process, even though the drug itself is carefully engineered. If you start at 30 mg and feel nothing, that does not mean you are a “non-responder.” It may just mean your conversion or receptor profile requires a higher dose. Conversely, if 30 mg makes you feel overstimulated, you are not being dramatic. Some adults are genuinely best served at 20 mg, which is below the typical starting dose for ADHD but still a real option.

Comparing Vyvanse Doses to Other Stimulants

Adults often want to know how a given dose of Vyvanse “translates” to other medications, especially if they are switching from Adderall or Ritalin. Formal dose equivalence between Vyvanse and other stimulants is not straightforward, because the prodrug mechanism, the duration of action, and the ratio of active isomers all differ. Reviews on stimulant substitution during drug shortages have noted that conversions must account for pharmacological differences between amphetamine and methylphenidate compounds, as well as isomer composition and release duration.³ Rough conversion charts exist and are used in clinical practice, but they are approximations, and your prescriber will typically plan to re-titrate after any switch rather than assume a “equivalent” dose translates perfectly.

As a very general ballpark, 70 mg of Vyvanse is sometimes compared to about 30 mg of mixed amphetamine salts (Adderall XR), but this number should not be taken as a precise equivalence. The release profiles are different, the subjective experience differs for many people, and the side-effect profile at supposedly equivalent doses can diverge. If you are switching medications, expect an adjustment period and communicate openly with your prescriber about what you notice.

Binge Eating Disorder Dosing Versus ADHD Dosing

Vyvanse is also approved for moderate-to-severe binge eating disorder (BED) in adults, and the dosing approach differs from ADHD. For BED, the recommended therapeutic dose range is 50 mg to 70 mg per day, with the titration still starting at 30 mg but with a clear expectation that the target dose will be at the higher end. Studies in BED populations used these higher doses to achieve a reduction in binge episodes, and 30 mg alone was generally not effective for that indication. If your prescriber is using Vyvanse for binge eating, they will likely push the dose higher than they might for ADHD, where 30 mg or 40 mg can be sufficient. The maximum of 70 mg per day still applies regardless of indication.

The Transition Problem From Adolescence to Adulthood

A related dosing issue that does not get enough attention is what happens when adolescents with ADHD age into adulthood. A claims database analysis across the United States found that more than 30% of patients who were on ADHD medication at age 17 had stopped treatment entirely by age 21.¹¹ Between ages 18 and 21, roughly 18% to 24% of patients experienced disrupted treatment, meaning gaps in prescriptions that suggest they fell through the cracks rather than making a deliberate choice to stop. Once treatment was disrupted, only about 16% to 22% resumed it each year, and those who stopped entirely had even lower return rates of just 3% to 4% per year.¹¹

This matters for dosing because many adults who are being prescribed Vyvanse for the first time in their twenties or thirties are actually returning to treatment after a gap, or are being diagnosed for the first time despite having had symptoms since childhood. Either way, these adults often start the titration process from scratch, even if they were on a stable dose as a teenager. Insurance changes, loss of a pediatric prescriber, and the general chaos of early adulthood all contribute to treatment gaps that reset the dosing conversation. If you find yourself restarting Vyvanse after a break of a year or more, expect to go back to 30 mg and titrate up again rather than jumping to whatever dose you were on before.

What “Average Dose” Really Means for Your Situation

Population averages for Vyvanse dosing are useful as a rough compass but unreliable as a map. Knowing that most adults end up somewhere between 40 mg and 70 mg tells you the general neighborhood, but it cannot tell you whether you will be the person who thrives on 30 mg with zero side effects or the person who needs every milligram of 70 mg to hold focus through a workday. The flat dose-response curve means you should not feel like you are underperforming if your dose is at the low end, and the side-effect gradient means you should not feel obligated to push to the maximum just because a higher dose exists. The best dose is the one where the balance between symptom relief and tolerability feels right for your daily life, and that number can only be found through the titration process your prescriber guides you through.